This post was originally published on this site
Investing.com – Shares of vaccine-makers traded higher on Monday after regulators approved boosters of their Covid-19 vaccines for all adults.
Moderna (NASDAQ:MRNA) and BioNTech (NASDAQ:BNTX) each traded around 2% higher, while Pfizer (NYSE:PFE), the German company’s partner in development and marketing of their Covid-19 vaccine, rose 0.3%.
Both the Centers for Disease Control and Prevention and the Food and Drug Administration Friday gave their nod to extra doses of their Covid-19 vaccines for people at least six months after their second shot.
Boosters were earlier advised for adults 65 and older and other vulnerable people.
Cases in some states have risen again lately soon after the Delta variant, the most rapidly-spreading of all coronaviruses, seemed to be waning.
Adults who got the single-dose Johnson & Johnson (NYSE:JNJ) vaccine were already eligible for Pfizer-BioNTech and Moderna boosters.
J&J stock traded 0.3% lower. The company is currently in the process of splitting its consumer health business into a separately listed entity.
